Zenas BioPharma Submits Investigational New Drug Application in China for ZB001 for the Treatment of Thyroid Eye Disease

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Related Keywords

China ,Shanghai ,United States ,America ,Zenas Biopharma ,China National Medical Products Administration ,Linkedin ,Drug Administration ,Viridian Therapeutics Inc ,Thyroid Eye Disease ,Chief Executive Officer ,Viridian Therapeutics ,Media Contact ,Health ,Globe Newswire ,